Aktuella utlysningar, vecka 51, 2023
Grants Office tipsar om aktuella utlysningar.
Svenska och nordiska utlysningar
Sigbrith Björkelunds Stiftelse
Sigbrith Björkelunds Stiftelse delar ut bidrag till kvinnliga forskare vid Karolinska Institutet eller Uppsala Universitet verksamma inom områdena neurologi, psykiatri eller hjärt-kärlsjukdomar. Stiftelsens bidrag avser i första hand att finansiera kostnader i samband med vistelse vid forskningsinstitution utanför Sverige, bidrag som på annat sätt stödjer mottagarens forskningsarbete kan även komma i fråga.
Mottagare ska ha avlagt läkarexamen och antingen befinna sig i senare delen av utbildningen på forskarnivå eller ha avlagt doktorsexamen under de fem senaste åren.
För utdelning 2024 avser Stiftelsen att lämna ett eller flera bidrag, preliminärt inom ramen 100 000 kronor. Ansökan ska vara Stiftelsen tillhanda senast 15 januari 2024 för medel som primärt avses att nyttjas under perioden juli 2024 – juni 2025.
Programme on Health Research - The Kavli Trust
Fund awards collaborative research projects addressing selected evidence gaps in child and adolescent mental health. The formal applicant must be a university, academic institution or research institution or institute in Norway, Sweden, Finland or the United Kingdom (host institution). The principal investigator must have a formal affiliation to the host institution, and could be either early career and emerging, or mid-career to established in field. The research project can not apply for less than NOK 3 M or more than NOK 10 M in total for the project period. Funding cannot be used for overhead. Host institution must provide a considerable in-kind contribution. Call is two stage.
Closing date: March 15, 2024.
Projektmedel - Svensk Sjuksköterskeförening (SSF)
Stöder sjuksköterskor som bedriver forsknings- och utvecklingsarbete, vill starta kliniska utvecklingsprojekt eller som är i början av sin forskarutbildning. Ansökan förutsätter medlemskap i föreningen. Med medel from Ulrica Cronés Stiftelsen, SSF stöder också legitimerad sjuksköterskor som på olika sätt arbetar med att förbättra omvårdnaden av svårt sjuka och döende patienter.
Closing date: March 8, 2024.
Obs! Call opens January 1, 2024.
More information - Svensk sjuksköterskeförening
More information - Ulrika Cronés fond
Research grants - Signe and Ane Gyllenberg Foundation
Foundation offers grants to support medical research in the following fields: (1) Medical research in psychosomatics, the basis being how the psyche affects the body; (2) Research in which a psychosomatic point of departure is expanded to include psychosocionomic questions; (3) Psychosomatic diseases; (4) Blood diseases; (5) Effect of mental factors on blood and blood circulation, effect of mental factors on other bodily systems and the related mechanisms that transmit the effects to the body; (6) Psychodynamics, which studies psychosomatic symptoms and attempts to describe their psychosomatic relationships. The foundation primarily supports Finnish research projects, but can also offer aid to researchers or research groups abroad.
Closing date: January 31, 2024.
Dr P. Håkanssons stiftelse
2024 års forskningsstöd, på 4.350 000 kronor delas ut till yngre forskare vid svenska universitet som utmärker sig inom områdena fysiologi, medicinsk kemi och livsmedelskemi (functional food).
Varje anslag/stipendium har tidigare år legat mellan 300.000-600.000 kronor. Projekt kan rekommenderas för tvååriga anslag.
Anslagen utbetalas till respektive universitet/institution enligt sedvanliga regler. Personliga post-doktorala utbildningsbidrag kan emellertid ges direkt till den person det avser.
Closing date: February 29, 2024
Stiftelsen Längmanska kulturfonden
Stiftelsen delar varje år ut ca 400 bidrag eller stipendier. Beloppen varierar mellan 15 000 kr och 50 000 kr.
Bidrag ges till tidsbegränsade projekt såsom forsknings- och konferensresor, arrangerande av konferenser, forskningsprojekt, materielinköp, samt framtagning (även arbetskostnader) och tryckning av böcker. Även doktorander och nydisputerade är välkomna att söka!
Endast digitala ansökningar emottages på apply.se/langmanska
Closing date: January 15, 2024
Europeiska utlysningar
Accelerate and promote responsible introduction of new DR-TB drugs and regimens
World Health Organization (WHO)
Unitaid, is pleased to announce this call for proposals aimed at maximizing the number of people cured from drug-resistant TB by supporting introduction and scale-up of new treatment regimens. Proposals should be carefully targeted, reflecting focused interventions to address key challenges regarding prevention, diagnosis, and treatment of drug-resistant TB in LMICs and access to health products, and target one or both of the following areas of work:
- Area 1: interventions encompassing community-led strategies for stimulating demand while simultaneously advancing human rights, equity, and quality of services within the national TB programs and where feasible the broader health systems and private sector;
- Area 2: Interventions to support countries in implementing innovative and targeted strategies for enhancing quality of TB services and care, case-finding and/or resistance monitoring.
Closing date: 10 January 2024
Pseudo-Obstruction Research Trust 2024 Small Grants Round
Bowel Research UK, in partnership with the Pseudo Obstruction Research Trust, invites applications for their grants. These support research into chronic intestinal pseudo obstruction, severe dysmotility, gastroparesis and other rare gastrointestinal neuromuscular disorders. Project must focus on a specific research question that delivers patient benefit.
Clinician and scientific investigators, including academic clinical lecturers, based at a UK or European university or hospital may apply. Researchers at an early stage of their career are encouraged to apply. The maximum award amount is £50,000.
Closing date: 12 January 2024
Travel Grant for the medicinal chemistry frontiers symposium
The European Federation for Medicinal Chemistry invites applications for its grants for the medicinal chemistry frontiers. These enable young academic scientists to participate in the medicinal chemistry frontiers symposium to be held in Utrecht, the Netherlands from 8 to 11 April 2024.
Members of an EFMC national adhering organisation may apply.
Closing date: 19 Jan 2024
2024 Balzan Prize - Biological Mechanisms of Ageing
The International Balzan Prize Foundation’s aim is to promote culture, the sciences, and the most meritorious initiatives in the cause of humanity, peace, and fraternity among peoples throughout the world.
The prize will be awarded in the following four subjects:
- Restorative Justice
- History of Modern and Contemporary Science
- Biological Mechanisms of Ageing
- Nanoporous materials for environmental applications
Each of the four 2024 Balzan Prizes is worth 750,000 Swiss francs. Half the Prize sum will be awarded to the Prizewinner in recognition of his/her work, while the other half will later be earmarked by the Prizewinner for research projects involving young researchers or research groups. The research proposal will be subject to the approval of the General Prize Committee.
Closing date: March 15, 2024
Amerikanska utlysningar
Federal Funding
NIH - Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) Funding Opportunity ID: PAR-24-088
Upcoming deadlines: Standard dates apply.
Abstract: The purpose of this Notice of Funding Opportunities (NOFOs) is to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds. Through this NOFO, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Eye Institute (NEI), and/or National Institute on Aging (NIA) and 2) discovery and/or validation of novel, biological targets that will inform studies of brain disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease-related biological targets and biological processes.
NIH - Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity ID: RFA-CA-24-018
Upcoming deadlines: 11th June, 2024; 15th November, 2024
Abstract: The purpose of this Notice of Funding Opportunity (NOFO) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this NOFO focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. To be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process must be included. Potential applicants who are interested in early-stage development or informatics resource sustainment should consult the companion NOFOs listed above.
NIH - Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
Funding Opportunity ID: PAR-24-092
Upcoming deadlines: Standard dates apply.
Abstract: This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives:
1) Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and
2) Improve approaches for testing, preventing, and treating HIV infection, and managing HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying current aging science approaches.
Proposed research must be consistent with the HIV/AIDS Research Priorities outlined by NIH s Office of AIDS Research (OAR) as described in NOT-OD-20-018.
NIH - Natural History, Clinical Outcome Assessment, and Biomarker Studies of Rare Neurodegenerative Diseases (U01) Clinical Trials Optional
Funding Opportunity ID: RFA-FD-24-024
Upcoming deadlines: 6th May, 2024
Abstract: The purpose of this funding opportunity announcement (FOA) is to support efficient natural history studies alone or in conjunction with the development and validation of clinical outcome assessments (COAs) and/or biomarker studies to address the unmet needs in rare neurodegenerative diseases for children and adults. Through the support of studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare neurodegenerative disease or multiple rare neurodegenerative diseases with similar pathophysiology, and facilitate rare disease product development.
Foundation
Williams Syndrome Association, US – Early Investigator Award
Upcoming deadlines: Applications are accepted on a rolling basis.
Amount: This award provides $85,000 per year for a total request of up to $170,000.
Indirect costs up to 15% may be included, but the total request (direct + indirect) may not exceed $170,000.
Eligibility: Postdoctoral fellows and clinical/research faculty within 5 years of their first faculty appointment may apply.
Abstract: This program is designed to provide financial support for early investigators studying any and all aspects of Williams syndrome, including medical, behavioral, and social research. We are interested in research aimed at improving patient care, developing or testing new therapies, new understanding of Williams syndrome, or any other research aimed at improving the health and well-being across the lifespan of individuals with Williams syndrome.
Citizens United for Research in Epilepsy (CURE), US – CURE Taking Flight Award
Upcoming deadlines: LOI – 9th January, 2024; Full application –26th March, 2024
Amount: Requests may be made for up to $125,000 for eighteen months. Funding requests may include salary support for the Principal Investigator (PI), technical staff, supplies necessary to perform the work, animal costs, publication fees, and travel to an epilepsy-related conference if the PI is presenting his/her CURE Epilepsy-funded research. Funds are not to be used to purchase equipment. Indirect costs are not supported.
Eligibility: You must fall into one of the following categories to be eligible for the Taking Flight Award:
A postdoctoral fellow with a PhD, PsyD, PharmD, or equivalent and a minimum of two years postdoctoral experience at the time of submission; A clinical fellow who is a Neurology Resident in his/her Neurology training and considering Epilepsy Fellowships; Newly appointed faculty within one year of having completed postdoctoral training; Clinician-researchers who are within two years of their faculty appointment.
Abstract: CURE Epilepsy awards grants for novel research projects that address finding the cures for epilepsy and address the goal of “no seizures, no side-effects.”. The Taking Flight Award seeks to promote the careers of early-career investigators to allow them to develop an independent research focus.
Thrasher Research Fund, US – E.W. "Al" Thrasher Awards
Upcoming deadlines: LOI – 18th January, 2024; Full application –26th April, 2024
Amount: $550,000USD. The grant amount is based on the actual budgetary needs of the project. The duration of the project can be up to three years. Indirect costs are no more than 7% of direct costs.
Eligibility: No restrictions.
Abstract: E.W. "Al" Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States. Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority. Hypothesis-driven research is critical, exploratory, or hypothesis-generating research will not be competitive.
Childhood Arthritis and Rheumatology Research Alliance CARRA, US – various research grants
Upcoming deadlines: Full application – 15h March
Amount: See link for individual program funding. Indirect costs are covered up to 8%.
Eligibility: The project PI must be a CARRA member in good standing (up to date on membership dues and membership information (location, contact information, and membership status) is current and accurate.
Abstract: CARRA is accepting applications for 4 new funding opportunities:
Mentored Career Development Award (MCDA) - This mentored award is intended to support an early career investigator (Fellow, Assistant Professor) who demonstrates a clear track record and commitment to developing an independent research career in pediatric rheumatology. Special consideration will be given to applications addressing the specific topics listed below, which were considered among patients, caregivers, and providers to be of critical importance: Precision medicine; Long-term health outcomes; and/or Treatment-related issues.
Health Equity Research Grant - This CARRA-Arthritis Foundation grant mechanism was established to support design (planning) activities for researchers to develop research projects that address topics along the health equity research spectrum.
Advancing Biospecimen Collection (ABC) Grant - The goal is to collect biosamples from patients enrolled in the CARRA Registry, to be used by CARRA investigators for future hypothesis-based research. This mechanism funds the collection of biosamples at CARRA Registry sites utilizing the CARRA Registry biosample consent form.
Large Grants – Large research grants for research on childhood arthritis and rheumatology. Special consideration will be given to applications addressing the specific topics listed below, which were considered among patients, caregivers, and providers to be of critical importance: Precision medicine; Long-term health outcomes; and/or Treatment-related issues.